A large body of literature demonstrates that recombinant Gal-9 is well-tolerated and exhibits therapeutic potential for a range of disorders in animal models [27–31], reinforcing its potential as a therapeutic tool for HIV infection. The gene discussed is LGALS9; the disease is HIV infectious disease.